Side effects of naltrexone observed in frequent tanners: Could frequent tanners have ultraviolet-induced high opioid levels? [1]

Journal of the American Academy of Dermatology

Volumn 52, Issue 5, 2005, Pages 916-

  Kaur, Mandeep ^a   Liguori, Anthony ^a   Fleischer Jr , Alan B ^a   Feldman, Steven R ^a,b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE; OPIATE ANTAGONIST; OPIATE PEPTIDE;

CLINICAL FEATURE; DISORIENTATION; FEMALE; HUMAN; LETTER; MEDICAL RESEARCH; MENTAL CONCENTRATION; NAUSEA AND VOMITING; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET RADIATION; WITHDRAWAL SYNDROME;

EID: 18144401626     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.02.026     Document Type: Article

References (6)

1. C. Scerra Addicted to the sun? Dermatol Times 24 2003 58
2. S.R. Feldman, A. Liguori, M. Kucenic, S.R. Rapp, A.B. Fleischer, and W. Lang UV exposure is a reinforcing stimulus in frequent indoor tanners J Am Acad Dermatol 51 2004 45 51
3. M. Wintzen, M. Yaar, J.P. Burbach, and B.A. Gilchrest Proopiomelanocortin gene product regulation in keratinocytes J Invest Dermatol 106 1996 673 678
4. P.C. Levins, D.B. Carr, J.E. Fisher, K. Momtaz, and J.A. Parrish Plasma beta-endorphin and beta-lipoprotein response to ultraviolet radiation Lancet 2 1983 166
5. M. Wintzen, D.M. Ostijn, M.C. Polderman, S. le Cessie, J.P. Burbach, and B.J. Vermeer Total body exposure to ultraviolet radiation does not influence plasma levels of immunoreactive beta-endorphin in man Photodermatol Photoimmunol Photomed 17 2001 256 260
6. T. Gambichler, A. Bader, M. Vojvodic, A. Avermaete, M. Schenk, and P. Altmeyer Plasma levels of opioid peptides after sunbed exposures Br J Dermatol 147 2002 1207 1211